ARCHIVES

Challoner: We Recommended FDA Replace 510(k) Clearance

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects

March 17, 1978

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

DCE Concepts Approved

March 7, 1986